Evidence mapPaperPMID 38533757Full record

ReviewJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2024

Strengths, weaknesses, opportunities, and threats of using AI-enabled technology in sleep medicine: a commentary.

Anuja Bandyopadhyay, Margarita Oks, Haoqi Sun, Bharati Prasad, Sam Rusk, Felicia Jefferson, Roneil Gopal Malkani, Shahab Haghayegh, Ramesh Sachdeva, Dennis Hwang and 9 more

Abstract readReview
In one paragraph

Review in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Anuja BandyopadhyayDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
Margarita OksDepartment of Medicine, Northwell Health System, New York, New York.
Haoqi SunDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Bharati PrasadDepartment of Medicine, University of Illinois, Chicago, Illinois.
Sam RuskEnsoData Research, EnsoData, Madison, Wisconsin.
Felicia JeffersonDepartment of Biochemistry and Molecular Biology, University of Nevada, Reno, Nevada.
Roneil Gopal MalkaniDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Shahab HaghayeghBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Ramesh SachdevaChildren's Hospital of Michigan and Central Michigan University College of Medicine, Detroit, Michigan.
Dennis HwangKaiser Permanente Southern California, Los Angeles, California.
Jon AgustssonNox Research, Nox Medical ehf, Reykjavik, Iceland.
Emmanuel MignotStanford University, School of Medicine, Stanford, California.
Michael SummersDivision of Pulmonary, Critical Care, and Sleep Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
Daniel FabbriVanderbilt University, Nashville, Tennessee.
Maryann DeakeviCore Healthcare, Boston, Massachusetts.
Matthew AnastasiAmerican Academy of Sleep Medicine, Darien, Illinois.
Andrew SampsonAmerican Academy of Sleep Medicine, Darien, Illinois.
Steve Van HoutAmerican Academy of Sleep Medicine, Darien, Illinois.
Azizi SeixasDepartment of Informatics and Health Data Science, University of Miami Miller School of Medicine, Miami, Florida.

Funding

Program to Increase Diversity in Faculty Engaged in Behavioral and Sleep Medicine (PRIDE)R25HL105444 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2023 to 2025
$831k
Personalized OSA treatment and effects on AD biomarkers and cognition among blacksR01AG075007 · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2025 to 2025
$739k
NHLBI NIH HHS R25 HL105444NIA NIH HHS R01 AG075007
6 · The paper itself

Abstract

Over the past few years, artificial intelligence (AI) has emerged as a powerful tool used to efficiently automate several tasks across multiple domains. Sleep medicine is perfectly positioned to leverage this tool due to the wealth of physiological signals obtained through sleep studies or sleep tracking devices and abundance of accessible clinical data through electronic medical records. However, caution must be applied when utilizing AI, due to intrinsic challenges associated with novel technology. The Artificial Intelligence in Sleep Medicine Committee of the American Academy of Sleep Medicine reviews advancements in AI within the sleep medicine field. In this article, the Artificial Intelligence in Sleep Medicine committee members provide a commentary on the scope of AI technology in sleep medicine. The commentary identifies 3 pivotal areas in sleep medicine that can benefit from AI technologies: clinical care, lifestyle management, and population health management. This article provides a detailed analysis of the strengths, weaknesses, opportunities, and threats associated with using AI-enabled technologies in each pivotal area. Finally, the article broadly reviews barriers and challenges associated with using AI-enabled technologies and offers possible solutions. CITATION: Bandyopadhyay A, Oks M, Sun H, et al. Strengths, weaknesses, opportunities, and threats of using AI-enabled technology in sleep medicine: a commentary.

Indexed as

Artificial IntelligenceSleep Medicine SpecialtyHumansartificial intelligencesleep medicine

Identifiers

PMID38533757
PMCPMC11217619

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.